Suchergebnisse - (Standardsuche:Subject:"angiotensin II "type1" receptor blockers")

PubPharm (120)

1

Angiotensin II receptor blockade is associated with preserved muscle strength in chronic hemodialysis patients

enthalten in: BMC nephrology | 2019

von Lin, Y. | Chen, S. | Lai, Y. | +4

2

Angiotensin receptor blocker vs ACE inhibitor effects on HDL functionality in patients on maintenance hemodialysis

enthalten in: Nutrition, metabolism, and cardiovascular diseases : NMCD | 2018

von Kaseda, R. | Tsuchida, Y. | Gamboa, J. | +11

3

Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension : an 8-week, multicenter, randomized, open-label, Phase IV clinical study

enthalten in: Drug design, development and therapy | 2018

von Han, S. | Oh, G. | Kwon, H. | +7

4

Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes : a post-hoc analysis from the PARADIGM-HF trial

enthalten in: The lancet. Diabetes & endocrinology | 2017

von Seferovic, J. | Claggett, B. | Seidelmann, S. | +10

CommentIn: Lancet Diabetes Endocrinol. 2017 May;5(5):314-315. - PMID 28330648

5

Pharmacokinetic and bioequivalence study comparing a candesartan cilexetil/rosuvastatin calcium fixed-dose combination with the concomitant administration of candesartan cilexetil and rosuvastatin calcium in healthy Korean subjects 

enthalten in: International journal of clinical pharmacology and therapeutics | 2017

von Park, D. | Jang, K. | Lee, J. | +4

6

Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice

enthalten in: Lipids in health and disease | 2017

von Verbeek, J. | Spincemaille, P. | Vanhorebeek, I. | +10

7

Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor

enthalten in: Drug design, development and therapy | 2017

von Zhang, W. | Bai, F. | Wang, J. | +4

8

Changeover Trial of Azilsartan and Olmesartan Comparing Effects on the Renin-Angiotensin-Aldosterone System in Patients with Essential Hypertension after Cardiac Surgery (CHAOS Study)

enthalten in: Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia | 2016

von Sezai, A. | Osaka, S. | Yaoita, H. | +4

9

COMPARATIVE BIOAVAILABILITY OF A FIXED-DOSE COMBINATION TABLET OF OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE IN HEALTHY KOREAN VOLUNTEERS

enthalten in: Acta poloniae pharmaceutica | 2016

von Zheng, R. | Hwang, H. | Kim, B.

10

Dyrk1A-ASF-CaMKIIδ Signaling Is Involved in Valsartan Inhibition of Cardiac Hypertrophy in Renovascular Hypertensive Rats

enthalten in: Cardiology | 2016

von Yao, J. | Qin, X. | Zhu, J. | +1

CommentIn: Cardiology. 2016;133(4):211-2. - PMID 26658690

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]